Cipla Ltd.

View in App
1168.00 -14.80 ▼-1.3%

04 October 2023, 03:04:57 PM
Volume: 855,924

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.cipla.com
Market Cap 94,109.93 Cr.
Enterprise Value(EV) 94,434.08 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 38.54 Trailing Twelve Months Ending 2023-06
Price-Earning Ratio (PE) 30.25 Trailing Twelve Months Ending 2023-06
Industry PE 38.26 Trailing Twelve Months Ending 2023-06
Book Value / Share 301.52 Trailing Twelve Months Ending 2023-06
Price to Book Value 3.87 Calculated using Price: 1,165.70
Dividend Yield 0.73 Period Ending 2023-03
No. of Shares Subscribed 80.73 Cr. 807,325,429 Shares
FaceValue 2
About Cipla Ltd.
The company is in the business of manufacturing, developing, and marketing wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs). The company has its wide network of manufacturing, trading and other incidental operations in India and International markets.

Cipla Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Cipla Ltd. Performance

View details >>
1 Day
-1.25%
1 Week
+0.37%
1 Month
-6.21%
3 Month
+16.59%
6 Month
+31.02%
1 Year
+3.29%
2 Year
+18.43%
5 Year
+78.44%
10 Year
+167.95%

Cipla Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 12.10 12.61 8.72 10.65 10.37 10.09 14.13 13.10 12.85
Return on Capital Employed (%) 15.33 13.24 8.28 10.20 11.94 12.53 17.85 17.24 18.19
Return on Assets (%) 7.85 7.28 4.97 6.52 6.50 6.56 9.95 9.94 10.19

Cipla Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Shh. Funds 10,050 10,801 11,516 12,544 14,229 15,012 15,763 18,327 20,842 23,408
Non Curr. Liab. 2,028 2,418 1,407 4,513 4,259 4,646 2,972 1,660 622 184
Curr. Liab. 2,564 3,881 7,776 3,374 3,832 3,772 4,393 4,591 4,913 5,033
Minority Int. 50 180 350 438 352 332 294 259 276 306
Equity & Liab. 14,692 17,281 21,049 20,869 22,673 23,762 23,423 24,837 26,652 29,007
Non Curr. Assets 9,040 9,689 12,208 12,064 11,859 11,335 11,717 11,628 11,925 11,732
Curr. Assets 5,652 7,591 8,841 8,736 10,814 12,425 11,704 13,181 14,711 16,805
Misc. Exp. not W/O
Total Assets 14,692 17,281 21,049 20,869 22,673 23,762 23,423 24,837 26,652 29,007

Cipla Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-06 Rs. Cr. TTM
Net Sales 11,345 13,595 14,394 15,156 16,362 17,132 19,160 21,763 22,753 23,707
Other Income 166 208 229 358 477 369 270 322 512 508
Total Income 11,511 13,803 14,623 15,513 16,839 17,501 19,429 22,085 23,265 24,215
Total Expenditure -9,184 -11,115 -11,919 -12,329 -13,265 -13,951 -14,911 -17,251 -17,763 -18,329
PBIDT 2,327 2,688 2,704 3,184 3,574 3,550 4,518 4,834 5,502 5,886
Interest -168 -207 -159 -114 -168 -197 -161 -106 -110 -108
Depreciation -505 -754 -1,323 -1,323 -1,326 -1,175 -1,068 -1,052 -1,172 -1,157
Taxation -400 -332 -180 -250 -570 -631 -889 -934 -1,203 -1,313
Exceptional Items -78 -182 -182 -182
PAT 1,254 1,395 1,042 1,419 1,510 1,547 2,401 2,559 2,835 3,126
Minority Interest -48 -23 -29 -6 35 47 16 -30 -31 -14
Share Associate -25 -12 -7 -3 -17 -47 -13 -13 -3 -1
Other Related Items
Consolidated Net Profit 1,181 1,360 1,006 1,411 1,528 1,547 2,405 2,517 2,802 3,111
Adjusted EPS 15 17 13 18 19 19 30 31 35 39

Cipla Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 1,563 1,173 1,741 2,382 1,463 1,691 3,068 3,755 3,326 3,238
Cash Fr. Inv. -1,250 -941 -4,523 -1,310 -854 -1,669 104 -2,387 -1,872 -2,389
Cash Fr. Finan. -266 165 3,104 -1,326 -385 -349 -2,949 -1,240 -1,600 -958
Net Change 48 397 322 -254 223 -326 224 129 -146 -109
Cash & Cash Eqvt 176 564 858 610 853 508 742 790 658 561

Cipla Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%)
Promoter 36.72 36.12 36.11 33.63 33.61 33.61 33.61 33.55 33.47
Public 63.28 63.88 63.89 66.37 66.39 66.39 66.39 66.45 66.53
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Cipla Ltd. Announcements

View details >>
Fri, 29 Sep 2023
Loss of Share Certificates
Cipla Limited has informed the Exchange about Loss of Share Certificates
Fri, 29 Sep 2023
ESOP/ESOS/ESPS
Cipla Limited has informed the Exchange regarding Allotment of 7951 Shares.
Fri, 29 Sep 2023
Alteration Of Capital and Fund Raising-XBRL
CIPLA LIMITED has informed the Exchange regarding Allotment of Securities

Cipla Ltd. Technical Scans

View details >>
Tue, 03 Oct 2023
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Decrease in 1 Month High Decrease in 1 Month
High Increase in 3 Months High Increase in 3 Months
High Increase in 6 Months High Increase in 6 Months

Cipla Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 273,992.06 1,123.40 -1.6%
Divi's Laboratories Ltd. 98,792.80 3,706.75 -0.5%
Dr. Reddy's Laboratories Ltd. 91,061.15 5,417.00 -0.8%
Apollo Hospitals Enterprise Ltd. 73,583.24 5,040.15 -1.5%
Mankind Pharma Ltd. 72,079.88 1,811.00 +0.7%
Torrent Pharmaceuticals Ltd. 63,636.20 1,862.65 -0.9%
Zydus Lifesciences Ltd. 61,790.00 604.00 -1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 32.48 1,123.40 -1.6%
Divi's Laboratories Ltd. Consolidated 2023-06 66.87 3,706.75 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 19.28 5,417.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 110.06 5,040.15 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 56.25 1,811.00 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 50.53 1,862.65 -0.9%
Zydus Lifesciences Ltd. Consolidated 2023-06 24.43 604.00 -1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.72 1,123.40 -1.6%
Divi's Laboratories Ltd. Consolidated 2023-06 7.53 3,706.75 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.71 5,417.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.73 5,040.15 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 5.89 1,811.00 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 9.68 1,862.65 -0.9%
Zydus Lifesciences Ltd. Consolidated 2023-06 3.32 604.00 -1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,123.40 -1.6%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,706.75 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,417.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,040.15 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,811.00 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 1,862.65 -0.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 604.00 -1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,123.40 -1.6%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,706.75 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,417.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,040.15 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,811.00 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,862.65 -0.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 604.00 -1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,123.40 -1.6%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,706.75 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,417.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,040.15 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,811.00 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,862.65 -0.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 604.00 -1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,123.40 -1.6%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,706.75 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,417.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,040.15 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,811.00 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 1,862.65 -0.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 604.00 -1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,123.40 -1.6%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,706.75 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,417.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,040.15 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,811.00 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 1,862.65 -0.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 604.00 -1.2%

Cipla Ltd. FAQ's

What is Cipla share price?
Can I buy Cipla shares now?
What is the Dividend Yield of Cipla?
What is the Market Cap of Cipla?
What are the key metrics to analyse Cipla?
What is the 52 Week High and Low of Cipla?
What is the trend of Cipla share price?